I Just Made the Biggest New Move of the Year

I made a move this week.

A big one. A bold one. The kind that will either look obvious in five years or will require everything I know about patience and conviction to sit through. I have made my peace with both outcomes.

This is a brand new stock position. I initiated it this week. And it has immediately moved into the number two spot in my portfolio by size, right behind Oscar Health. That tells you everything about the level of conviction behind it.

This is not a trade. This is not a hedge. This is not a speculative allocation. This is a deliberate, high-conviction, long-horizon bet on one of the most powerful structural growth stories on earth, available today at a price that the market has handed us as a gift because of short-term noise that has nothing to do with the long-term thesis.

I am writing this because paid members of FJ Research deserve to know what I am doing with my own capital in real time. That transparency is the most valuable thing I can offer. When I move, you know. When I hold, you know. When I sell, you know. That is the deal.

The name of the company, the full position sizing rationale, and the complete valuation framework are exclusively for paid members.

$49 a year. 13 cents a day. If one move like this matters, the subscription has paid for itself many times over.

If you’re on the free tier, today is the day to change that. Subscribe now.

Paid subscribers: the full update continues below.